SS-31 (also known as Elamipretide, MTP-131, or Bendavia) is a synthetic
mitochondria-targeting tetrapeptide designed to selectively bind and stabilize cardiolipin on the
inner mitochondrial membrane. Research has focused heavily on its potential to improve ATP production, reduce
oxidative stress, support mitochondrial structure, and enhance cellular resilience in high-demand or aging tissues.
Its unique intracellular mechanism distinguishes SS-31 from traditional receptor-based peptides, positioning it
as a leading molecule in mitochondrial biology, metabolic research, cardiovascular studies, neuroprotection,
and muscle-performance science.
CAS #: 736992-21-5
Formula: C32H49N9O5
M.W.: 639.8 g/mol
SS-31 selectively binds cardiolipin within the inner mitochondrial membrane, helping to stabilize electron-transport
chain supercomplexes, reduce electron leakage, maintain membrane curvature, and improve oxidative phosphorylation efficiency.
By optimizing ETC function, SS-31 may lower mitochondrial ROS production through improved electron flow, stabilized
membrane potential, and prevention of cardiolipin peroxidation.
SS-31 is widely studied for its potential to improve ATP output by supporting efficient ETC activity, optimizing
mitochondrial respiration, and enhancing energy availability during cellular stress.
Research indicates SS-31 may reduce release of pro-apoptotic factors, improve mitochondrial resilience under injury,
and enhance cell survival in stressed, inflamed, or oxygen-deprived tissues.
SS-31 is a major molecule in mitochondrial-aging research due to its potential to restore membrane potential, improve
bioenergetic capacity, reduce oxidative stress, and normalize mitochondrial dynamics.
Cardiac muscle is highly mitochondrial, making SS-31 a strong research candidate for ischemia/reperfusion injury,
cardiac energetics, endothelial dysfunction, and ATP depletion in stressed cardiac tissue.
SS-31 is studied in neural models for its ability to reduce neuronal oxidative stress, support mitochondrial transport,
promote synaptic resilience, and protect against age-related neurodegeneration.
Research indicates SS-31 may influence muscle fatigue resistance, exercise-induced mitochondrial stress, age-related
muscle decline, and ATP availability during physical activity.
SS-31 has been evaluated in studies of kidney ischemia, liver oxidative stress, diabetic mitochondrial dysfunction,
and whole-body energy imbalance.
SS-31 (Elamipretide) is a specialized mitochondrial-targeting tetrapeptide extensively studied for enhancing ATP
production, reducing oxidative stress, stabilizing mitochondrial membranes, and improving cellular resilience. Its
cardiolipin-binding mechanism sets it apart from conventional peptides, making it a leading compound in research
focused on aging, metabolic balance, cardiac energetics, neuroprotection, and muscle performance.
Having trouble viewing? Use the buttons below to download or open the certificate.
In Stock